{"id":"W4205703018","doi":"10.1016/j.jval.2021.11.311","title":"POSB38 Developing a Cost-Effectiveness Analysis for Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in the Absence of Overall Survival Data","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Nivolumab; Esophageal cancer; Internal medicine; Clinical trial; Cancer; Oncology; Cancer registry; Population; Clinical endpoint; Adjuvant; Surgery; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007317109,0.001075486,0.001657297,0.001311468,0.0001863654,0.002323232,0.000736377,0.001033958,0.007006489],"category_scores_gemma":[0.01685178,0.0006261566,0.005092009,0.001110667,0.0002557878,0.001369223,0.0006889753,0.001773202,0.0004277944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003392349,"about_ca_system_score_gemma":0.003737115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008791358,"about_ca_topic_score_gemma":0.006610706,"domain_scores_codex":[0.9961993,0.003004779,0.0001277801,0.0002180036,0.0002741564,0.000175942],"domain_scores_gemma":[0.9939983,0.004974716,0.0003107552,0.0001512034,0.0003565469,0.0002084745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03941251,0.001422874,0.04131627,0.0038466,0.02603381,0.000582166,0.00008866467,0.6175588,0.003508621,0.01984656,0.017052,0.229331],"study_design_scores_gemma":[0.01398264,0.008665694,0.03062176,0.001691915,0.02021619,0.0004467268,0.0002213924,0.8787733,0.002826778,0.02274482,0.01966377,0.0001449695],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7905659,0.03282641,0.09655452,0.01837406,0.001292472,0.004720083,0.01851751,0.0004687243,0.03668036],"genre_scores_gemma":[0.9716321,0.002800203,0.01591695,0.001511235,0.0002325688,0.0006898742,0.004125692,0.00006590793,0.003025461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008791358,"threshold_uncertainty_score":0.03869706,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1425764927853168,"score_gpt":0.4098016590696071,"score_spread":0.2672251662842904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}